Compare · MDLN vs MMED
MDLN vs MMED
Side-by-side comparison of Medline Inc. (MDLN) and MiniMed Group Inc. (MMED): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and MMED operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.15B, about 11.0x MMED ($4.00B).
- MDLN has been more active in the news (20 items in the past 4 weeks vs 7 for MMED).
- MDLN has more recent analyst coverage (25 ratings vs 12 for MMED).
- Company
- Medline Inc.
- MiniMed Group Inc.
- Price
- $33.60-2.50%
- $14.21+1.00%
- Market cap
- $44.15B
- $4.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2026
- News (4w)
- 20
- 7
- Recent ratings
- 25
- 12
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest MMED
- MiniMed Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
- MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook
- MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions
- MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
- New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System
- MiniMed Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- The Benchmark Company initiated coverage on MiniMed with a new price target
- SEC Form SCHEDULE 13G filed by MiniMed Group Inc.
- MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System